Guiyang Xintian Pharmaceutical Co., Ltd. logo

Guiyang Xintian Pharmaceutical Co., Ltd. (002873)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
8. 30
+0.04
+0.4843%
¥
2.64B Market Cap
- P/E Ratio
0.24% Div Yield
6.84M Volume
- Eps
¥ 8.26
Previous Close
Add Transaction
Day Range
8.18 8.43
Year Range
7.04 15.19
Want to track 002873 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002873 closed today higher at ¥8.3, an increase of 0.4843% from yesterday's close, completing a monthly increase of 13.5431% or ¥0.99. Over the past 12 months, 002873 stock lost -16.5829%.
002873 pays dividends to its shareholders, with the most recent payment made on May 27, 2026. The next estimated payment will be in In 9 months on May 27, 2027 for a total of ¥0.03.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0148%, based on the last three reports.
Guiyang Xintian Pharmaceutical Co., Ltd. has completed 3 stock splits, with the recent split occurring on Oct 28, 2022.
The company's stock is traded on one exchange.

002873 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Guiyang Xintian Pharmaceutical Co., Ltd. (002873) FAQ

What is the stock price today?

The current price is ¥8.30.

On which exchange is it traded?

Guiyang Xintian Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002873.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.24%.

What is its market cap?

As of today, the market cap is 2.64B.

Has Guiyang Xintian Pharmaceutical Co., Ltd. ever had a stock split?

Guiyang Xintian Pharmaceutical Co., Ltd. had 3 splits and the recent split was on Oct 28, 2022.

Guiyang Xintian Pharmaceutical Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Da Lun Dong CEO
XSHE Exchange
CNE100002QB5 ISIN
CN Country
1,682 Employees
27 May 2026 Last Dividend
4 Jul 2018 Last Split
- IPO Date

Overview

Guiyang Xintian Pharmaceutical Co.,Ltd., established in 1995, is a prominent player in the Chinese pharmaceutical industry, focusing on the research, development, production, and sale of new Chinese patent medicines. The company is committed to addressing a wide range of diseases through its innovative products. Based in Guiyang, China, Guiyang Xintian Pharmaceutical has carved a niche for itself in the realm of traditional Chinese medicine, offering solutions that cater to various therapeutic categories.

Products and Services

Guiyang Xintian Pharmaceutical Co.,Ltd. offers a diverse portfolio of formulation products designed to meet various healthcare needs, including:

  • Hard Capsules: These are designed for easy oral consumption and are formulated for precise dosage delivery of medication.
  • Granules: Offering a versatile dosage form, granules are suitable for a range of conditions, providing ease of use and dose flexibility.
  • Tablets: A common form of medication, tablets are manufactured to meet various therapeutic needs, ensuring consistent dose and efficacy.
  • Mixtures: These liquid formulations are designed for conditions requiring multiple ingredients, ensuring therapeutic precision and patient compliance.
  • Syrups: Syrups offer an alternative for patients who have difficulty with solid dosage forms, commonly used in pediatric and geriatric medicine.
  • Liquors: Medicinal liquors incorporating traditional Chinese medicine ingredients for various treatments.
  • Dews: Dew-like formulations are another innovative approach to delivering medicine, often used for ease of application to certain conditions.
  • Powders: These are versatile formulations that can be designed for oral or external application, suited for a wide range of therapeutic areas.
  • Suspensions: Liquid formulations where solid particles are dispersed within a liquid, often used for patients who find tablets and capsules difficult to swallow.
  • Gels: Designed for external application, gels are used particularly in the treatment of dermatological conditions.

The company specializes in treatments across various domains including anti-tumor, gynecological, urological diseases, breast thyroid, blood supplement, heat clearing type, oral, anti-cold, and cardiovascular diseases. This comprehensive approach allows Guiyang Xintian Pharmaceutical to cater to a broad spectrum of healthcare needs, leveraging the rich heritage of Chinese patent medicines.

Contact Information

Address: No. 3 Gaoxin North Road, Guiyang, China, 550000
Phone: 86 85 1863 17787